A streamlined, cell-free platform for accelerated mRNA production
The VUB Translational Oncology Research Centre and the Laboratory for Molecular and Cellular Therapy have developed a modular rapid DNA-to-RNA (RDR) platform. It offers a streamlined, fully enzymatic, cell-free workflow that enables a fast, flexible, and scalable process without bacterial cloning and plasmid amplification, making it well suited to high-throughput discovery applications.
Built on a synthetic oligonucleotide-based strategy, the platform uses just one or, at most, two oligonucleotides to generate DNA templates through PCR. Flexible template design enables rapid sequence modifications, facilitating efficient and rapid validation of multiple therapeutic candidate targets before downstream preclinical application.
At a glance: RAPID DNA-TO-RNA TECHNOLOGY
Translational Oncology Research Centre (TORC)
Prof. Dr. Karine Breckpot
Director, Laboratory for Molecular and Cellular Therapy
[E] Karine.Breckpot@vub.be
Prof. Dr. Lorenzo Franceschini
Scientific and Operational Manager, Molecular Biology Core Facility
[E] Lorenzo.Franceschini@vub.be